Thyrocare Technologies Ltd - 539871 - Financial Results For The Quarter And Half Year Ended September 30, 2023
Financial results for the quarter and half year ended September 30, 202331-10-2023
31-10-2023
Thyrocare Technologies Ltd - 539871 - Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2023
In continuation of our prior intimation dated October 23, 2023 regarding holding of a meeting of the Board of Directors of the Company ("Board"), we wish to inform you that the Board, at its meeting held today i.e. October 31, 2023, inter alia, considered and approved the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2023.31-10-2023
Thyrocare Technologies Ltd - 539871 - Assessment Order Passed By The Navi Mumbai Municipal Corporation, Cess Department
Assessment order passed by the Navi Mumbai Municipal Corporation, cess Department28-10-2023
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor call intimation25-10-2023
Thyrocare Technologies Ltd - 539871 - Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended September 30, 2023.
Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 ,inter alia, to consider and approve Board Meeting intimation23-10-2023
Thyrocare Technologies Ltd - 539871 - Closure of Trading Window
Intimation of trading window closure29-09-2023
Thyrocare Technologies Ltd - 539871 - Entered Into A Subscription Agreement At Tanzania
Entered into a subscription agreement19-09-2023
Thyrocare Technologies Ltd - 539871 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report of Thyrocare Technologies Limited.14-09-2023
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor call intimation31-08-2023
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the scheduled Investor Meeting which will be attended by the representatives of the Company25-08-2023